Analyst Price Targets — NVAX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 24, 2025 11:45 am | — | Cantor Fitzgerald | $18.00 | $8.55 | TheFly | Novavax initiated with an Overweight at Cantor Fitzgerald |
| October 23, 2025 12:20 pm | Sean Lee | H.C. Wainwright | $11.00 | $8.46 | TheFly | Novavax price target raised to $11 from $10 at H.C. Wainwright |
| November 18, 2024 12:39 pm | Mayank Mamtani | B.Riley Financial | $22.00 | $7.58 | StreetInsider | Novavax (NVAX) PT Lowered to $22 at B.Riley |
| October 16, 2024 1:29 pm | Roger Song | Jefferies | $25.00 | $10.15 | StreetInsider | Novavax (NVAX) PT Lowered to $25 at Jefferies |
| October 16, 2024 11:43 am | Alec Stranahan | Bank of America Securities | $14.00 | $10.45 | StreetInsider | Novavax (NVAX) PT Lowered to $14 at BofA Securities 'to reflect delays in phase 3 CIC/standalone flu trial' |
| July 19, 2024 11:37 am | Roger Song | Jefferies | $31.00 | $14.36 | TheFly | Novavax price target lowered to $31 from $38 at Jefferies |
| May 10, 2024 10:56 am | Vernon Bernardino | H.C. Wainwright | $19.00 | $9.94 | TheFly | H.C. Wainwright reiterates Buy rating on Novavax after 'landmark' Sanofi deal |
| February 14, 2022 12:00 am | Charles Duncan | Cantor Fitzgerald | $174.00 | $80.11 | Pulse 2.0 | Novavax (NVAX) Stock: $174 Price Target From Cantor Fitzgerald |
Latest News for NVAX
Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Shares of Novavax, Inc. (NASDAQ: NVAX - Get Free Report) have received an average rating of "Hold" from the ten ratings firms that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and five have given a buy recommendation to the company.
In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for NVAX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.